(Q33312296)

25 July 2017

title

Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial (English)

1 reference

25 July 2017

1 reference

Luca Incrocci

1

1 reference

25 July 2017

A Koos Slob

series ordinal

2

1 reference

25 July 2017

Wim C J Hop

series ordinal

3

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

70

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

1190-1193

1 reference

25 July 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Cancer in the European community and its member states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Sexual (dys)function after radiotherapy for prostate cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Tadalafil pharmacokinetics in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.08.029

10.1016/J.UROLOGY.2007.08.029

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference